Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease.

Author:

Stamler J1,Neaton J D1,Wentworth D N1

Affiliation:

1. Department of Community Health and Preventive Medicine, Northwestern University Medical School, Chicago, Illinois 60611.

Abstract

Among the 356,222 men screened for the Multiple Risk Factor Intervention Trial who had no history of hospitalization for heart attack at entry, more than 2,000 coronary deaths occurred during 6 years of follow-up. With this large data set, detailed cross-tabulations clearly and simply showed the strong graded relation between blood pressure and coronary heart disease death. This risk gradient was evident in each of five age groups ranging from 35 to 57 years and for levels of diastolic blood pressure ranging from less than 75 mm Hg to greater than 115 mm Hg. Systolic blood pressure was more strongly associated with coronary heart disease death than was diastolic blood pressure, and isolated systolic blood pressure elevation was found to be an important risk factor in these middle-aged men. The risk of coronary death was increased among hypertensive men who had elevated serum cholesterol levels or who smoked cigarettes. Because less than 10% of hypertensive men had cholesterol levels in the lowest quintile (below 182 mg/dl) and were nonsmokers, a multi-intervention approach for the large majority of hypertensive persons is clearly indicated. Risks of death were also substantially increased among those hypertensive men who already had end-organ damage, emphasizing the importance of early treatment to prevent such damage. These findings have implications for the design of prevention trials and clinical practice, as it is clear that systolic as well as diastolic blood pressure should be considered in treating hypertensive patients. Additionally, treatment goals should be directed at preventing not only death but many other morbid events, clinical and subclinical, that are associated with elevated blood pressure and that are preventable with appropriate treatment.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference37 articles.

1. Stamler J: Lectures on Preventive Cardiology. Grune & Stratton Inc New York 1967 pp 1-434

2. Inter-Society Commission for Heart Disease Resources. Atherosclerosis Study Group and Epidemiology Study Group: Primary prevention of the atherosclerotic diseases. Circulation 197O;42:A55-A95

3. Stamler J: High blood pressure in the United States-An overview of the problem and the challenge. National Conference on High Blood Pressure Education-Report of Proceedings. US Dept of Health Education and Welfare Public Health Service National Institutes of Health Dept of Health Education and Welfare publication No. (N1H) 73-486. Washington DC US Government Printing Office 1973 pp 11-66

4. Framingham Research Group and Pooling Project Research Group: The results of the Framingham Study applied to four other U.S.-based epidemiologic studies of cardiovascular disease in Kannel WB Gordon T (eds): The Framingham Study-An Epidemiological Investigation of Cardiovascular Disease. Section 31 US Dept of Health Education and Welfare Public Health Service Dept of Health Education and Welfare publication No. (NIH) 76-1083. Washington DC US Government Printing Office 1976 pp 1-65

5. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling project

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3